SCHADE CHRISTIAN S

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
SCHADE CHRISTIAN S's trades of Aprea Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
499.92
Quantity 77,608 +40.7%
Value US$2,026,161
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-19 2022-05-18
B Purchase
62,711 +7.3%
328.57
US$3,806,381 		62,711 +7.3% 328.57 US$3,806,381
2019-10-07 2019-10-07
B Purchase
77,608 +40.7%
499.92
US$2,026,161 		77,608 +40.7% 499.92 US$2,026,161
2019-10-07 2019-10-07
B Purchase
42,691 -39.1%
312.29
US$3,071,937 		42,691 -39.1% 312.29 US$3,071,937
2019-10-07 2019-10-07
B Purchase
1,000 +inf%
15.00
US$15,000 		1,000 +inf% 15.00 US$15,000
2019-10-07 2019-10-07
B Purchase
1,000 +inf%
15.00
US$15,000 		1,000 +inf% 15.00 US$15,000
2019-10-07 2019-10-07
B Purchase
1,000 +inf%
15.00
US$15,000 		1,000 +inf% 15.00 US$15,000
2019-10-07 2019-10-07
B Purchase
1,000 +inf%
15.00
US$15,000 		1,000 +inf% 15.00 US$15,000
2019-10-07 2019-10-07
B Purchase
1,000 +inf%
15.00
US$15,000 		1,000 +inf% 15.00 US$15,000
2019-05-14 2019-05-10
S Sale
15,658 -32.4%
51.56
US$807,328 		15,658 -32.4% 51.56 US$807,328